Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
60%(6 trials)

Phase Distribution

Ph phase_2
1
8%
Ph phase_3
1
8%
Ph phase_4
9
75%

Phase Distribution

0

Early Stage

1

Mid Stage

10

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
9(81.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(10)
Terminated(1)
Other(1)

Detailed Status

Completed10
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (9.1%)
Phase 31 (9.1%)
Phase 49 (81.8%)

Trials by Status

unknown18%
withdrawn18%
completed1083%

Recent Activity

0 active trials
Showing 5 of 12
unknownphase_4

Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section

NCT02571881
completedphase_3

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

NCT01885182
completedphase_2

A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain

NCT00513656
completedphase_4

A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients

NCT01313780
withdrawnphase_4

Treatment of Chronic Pain From Osteoarthritis

NCT02032927
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT02571881Phase 4

Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section

Unknown
NCT01885182Phase 3

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

Completed
NCT00513656Phase 2

A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain

Completed
NCT01313780Phase 4

A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients

Completed
NCT02032927Phase 4

Treatment of Chronic Pain From Osteoarthritis

Withdrawn
NCT01811186Phase 4

An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY)

Completed
NCT02516059Phase 4

Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia

Completed
NCT01719757Phase 4

PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain

Completed
NCT01811238Phase 4

An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal Disorders

Completed
NCT02293785

GREAT - Good Response With Appropriate Treatment

Completed
NCT02573922Phase 4

Opioid Induced Bowel Dysfunction in Patients Undergoing Spinal Surgery

Completed
NCT00784810Phase 4

A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12